Spikevax

BIOLOGICAL2 trials

Sponsors

Jules Bordet Institute, ModernaTX, Inc.

Conditions

CancerSARS-CoV-2

Phase 4

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2

TerminatedNCT05075538

Jules Bordet InstituteCancer

Start: 2021-12-01End: 2024-01-08Updated: 2024-01-17

Unknown Phase

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

CompletedNCT06130345

ModernaTX, Inc.SARS-CoV-2

Start: 2023-04-14End: 2024-08-31Updated: 2024-12-19